Korean expansion

December 17, 2010

AB SCIEX has announced that the company has expanded its commercial operations in Korea. The company created a new direct sales organization under AB SCIEX Korea to help customers located in Korea through the use of mass spectrometry technologies.

AB SCIEX has announced that the company has expanded its commercial operations in Korea. The company created a new direct sales organization under AB SCIEX Korea to help customers located in Korea advance drug discovery, biomedical science, food and environmental safety testing, forensics and clinical research through the use of mass spectrometry technologies.

“AB SCIEX has a commitment to invest for long-term growth in emerging markets, such as Korea,” said Vince Gao, senior director, APAC sales, support and customer service, AB SCIEX. “The expansion of our commercial team elevates our presence in Korea and positions us to better serve our Korean customers. With the integration of the sales, service and support functions into AB SCIEX Korea, we will be able to make faster decisions and simplify the purchase process, so our customers can focus on achieving their goals.”

This expansion was made possible by an agreement with Life Science Korea (LSK) to transfer existing sales, service and marketing personnel to AB SCIEX, effective immediately. LSK was formerly the company’s official dealer in Korea; but by shifting from indirect to direct sales, the company intends to enhance customer support and collaborations by providing one point of contact for pre-sale demonstrations, purchase, installation, application support and service.

For more information visit the company’s website at www.absciex.com